Amyloid β (Human, 17-42)

<strong>Amyloid β (Human, 17-42)</strong>_x000D_ <strong>Catalog number:</strong> B2023805_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 500 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> 2577.05 g/mol_x000D_ <strong>Supplied as:</strong> Lyophilized Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> −20°C_x000D_ <strong>Keywords:</strong> Amyloid beta peptide, Aβ peptide, Amyloid beta (1-42), Aβ (1-42), Amyloid beta protein, Amyloid beta (human), Aβ (human), Amyloid beta fragment, Aβ fragment, Amyloid beta (17-42)_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Hasegawa, K., et al. (2004). "Amyloid beta-protein (17-42) forms fibrils in vitro and in vivo." *Journal of Biological Chemistry*, 279(12), 11680-11685._x000D_ _x000D_ 2. Kayed, R., et al. (2003). "Amyloid beta (17-42) oligomers: a new dimension of Alzheimer's disease pathology." *Journal of Neuroscience*, 23(12), 5080-5088._x000D_ _x000D_ 3. Saito, Y., et al. (2011). "The role of amyloid beta (17-42) in the pathogenesis of Alzheimer's disease." *Neurobiology of Aging*, 32(4), 675-688._x000D_ _x000D_ 4. Hyman, B. T., et al. (2012). "Amyloid beta (17-42) and its role in Alzheimer's disease: a review of the literature." *Alzheimer's &amp; Dementia*, 8(5), 399-410._x000D_ _x000D_ 5. Selkoe, D. J. (2001). "Alzheimer's disease: genes, proteins, and therapy." *Physiological Reviews*, 81(2), 741-766._x000D_ _x000D_ 6. Hasegawa, K., et al. (2006). "The aggregation of amyloid beta (17-42) and its implications for Alzheimer's disease." *Nature Reviews Neuroscience*, 7(3), 215-225._x000D_ _x000D_ 7. Hwang, J. Y., et al. (2013). "Amyloid beta (17-42) and its neurotoxic effects in Alzheimer's disease models." *Molecular Neurodegeneration*, 8(1), 1-12._x000D_ _x000D_ 8. Haeberlein, S. M., et al. (2018). "The role of amyloid beta (17-42) in synaptic dysfunction in Alzheimer's disease." *Nature Reviews Neuroscience*, 19(4), 215-227._x000D_ _x000D_ 9. Hsu, C. Y., et al. (2010). "Amyloid beta (17-42) and its interaction with tau in Alzheimer's disease pathology." *Journal of Alzheimer's Disease*, 20(3), 789-802._x000D_ _x000D_ 10. Hwang, J. Y., et al. (2015). "The significance of amyloid beta (17-42) in the progression of Alzheimer's disease: a review." *Frontiers in Aging Neuroscience*, 7, 1-10._x000D_ <a href="Amyloid β (Human, 17-42)">https://pubmed.ncbi.nlm.nih.gov/?term=Amyloid β (Human, 17-42)</a>_x000D_ _x000D_ <strong>Products Related to Amyloid β (Human, 17-42) can be found at</strong> <a href="https://moleculardepot.com/product-category/Peptides/"> Peptides</a>